Familial Danish Dementia (FDD), an early-onset non-amyloid-β (Aβ) cerebral amyloidosis, is neuropathologically characterized by widespread cerebral amyloid angiopathy, parenchymal amyloid and preamyloid deposits, as well as neurofibrillary degeneration indistinguishable to that seen in Alzheimer's disease (AD). The main amyloid subunit composing FDD lesions, a 34-amino acid de-novo generated peptide ADan, is the direct result of a genetic defect at the 3′-end of the BRI2 gene and the physiologic action of furin-like proteolytic processing at the C-terminal region of the ADan precursor protein. We aimed to study the impact of the FDD mutation, the additional formation of the pyroglutamate (pE) posttranslational modification as well as the relevance of C-terminal truncations -all major components of the heterogeneous FDD deposits-on the structural and neurotoxic properties of the molecule. Our data indicates that whereas the mutation generated a β-sheet-rich hydrophobic ADan subunit of high oligomerization/fibrillization propensity and the pE modification further enhanced these properties, C-terminal truncations had the opposite effect mostly abolishing these features. The potentiation of pro-amyloidogenic properties correlated with the initiation of neuronal cell death mechanisms involving oxidative stress, perturbation of mitochondrial membrane potential, release of mitochondrial cytochrome c, and downstream activation of caspase-mediated apoptotic pathways. The amyloid-induced toxicity was inhibited by targeting specific components of these detrimental cellular pathways, using reactive oxygen scavengers and monoclonal antibodies recognizing the pathological amyloid subunit. Taken together, the data indicate that the FDD mutation and the pE posttranslational modification are both primary elements driving intact ADan into an amyloidogenic/neurotoxic pathway while truncations at the C-terminus eliminate the proamyloidogenic characteristics of the molecule, likely reflecting effect of physiologic clearance mechanisms.
Introduction
Familial Danish Dementia (FDD) is a rare autosomal dominant, early-onset neurodegenerative disorder. Also termed heredopathia opthalmo-oto-encephalica (Stromgren et al., 1970) , the disease is clinically characterized by cataracts, deafness, progressive ataxia, and dementia. Cataracts are typically the first manifestation of the disease, developing before the age of 30, followed by hearing loss about 10-20 years later and cerebellar ataxia shortly after the age of 40. Paranoid psychosis and severe dementia appear after the age of 50, whereas the median age of death is 58 years (Stromgren et al., 1970; Bek, 2000) . Neuropathologically, FDD is characterized by brain atrophy, diffuse parenchymal preamyloid and amyloid lesions in nearly all areas of the central nervous system (CNS), occasional compact plaques, widespread amyloid angiopathy, and hippocampal neurofibrillary degeneration strikingly similar -if not identical-to that seen in Alzheimer's disease (AD) (Vidal et al., 2000; Holton et al., 2002) . Amyloid deposition in retinal blood vessels and parenchyma has been linked to retinal neovascularization leading to vitreous hemorrhage, and neovascular glaucoma (Bek, 2000; Holton et al., 2002) . Despite widespread amyloid angiopathy in the small blood vessels and capillaries of the cerebrum, choroid plexus, and cerebellum, cerebral hemorrhage is rare.
FDD results from a mutation in the coding region of the BRI2 gene located in the long arm of chromosome 13. BRI2 normally encodes a
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Abbreviations: Aβ, amyloid-β; AD, Alzheimer's disease; ANS, 8-anilinonapthalene-1-sulfonic acid; CAA, cerebral amyloid angiopathy; CAPS, 3-cyclohexamino-1-propanesulfonic acid; CD, circular dichroism; CNS, central nervous system; cyt c, cytochrome c; DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate; DMSO, dimethylsulfoxide; ECL, enhanced chemiluminescence; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; FDD, familial Danish dementia; HFIP, hexafluoroisopropanol; HRP, horseradish peroxidase; IF, immunofluorescence; LDH, lactate dehydrogenase; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; PBS, phosphate buffered saline; pE, pyroglutamate; PVDF, polyvinylidene fluoride; ROS, reactive oxygen species; RT, room temperature; SDS, sodium dodecyl sulfate; TBST, Tris-buffered saline containing 0.1% Tween 20; ThT, thioflavin T; WB, Western blot.
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